Teladoc Health, Eli Lilly Partner to Add GLP-1 Self-Pay Option to Comprehensive Weight Care

What You Should Know: 

– Teladoc Health, the global leader in virtual care announced a partnership with Gifthealth, a digital pharmacy platform and partner of Eli Lilly’s LillyDirect program, to improve access to tirzepatide (brand name Mounjaro) for weight management. 

– The collaboration will enable eligible Teladoc Health members enrolled in the Comprehensive Weight Care Program to receive convenient and affordable access to this FDA-approved medication.

Streamline Access to Tirzepatide for Weight Management

Tirzepatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has shown significant efficacy in clinical trials for weight loss. However, access to this medication can be challenging for some individuals due to insurance coverage limitations or high costs.

Through this partnership, eligible Teladoc Health members who are prescribed tirzepatide by their Teladoc Health provider can have single-use vials delivered directly to their homes through Gifthealth. This streamlined process eliminates the need for patients to visit a pharmacy and simplifies access to this important medication.

Comprehensive Weight Care Program

In addition to streamlined access to tirzepatide, Teladoc Health’s Comprehensive Weight Care Program offers a holistic approach to weight management, including:

• Multi-disciplinary care: Access to licensed clinicians with expertise in obesity medicine, registered dietitians, and health coaches.
• Personalized support: Tailored guidance and support to help members achieve their weight loss goals.
• Connected devices: Integration with digital scales and other devices to track progress and monitor health metrics.
• Lifestyle coaching: Personalized coaching on nutrition, exercise, and behavior change.
• Mental health support: Access to mental health professionals to address emotional and psychological factors related to weight.

“At Teladoc Health, we are dedicated to expanding access to clinically responsible, evidence-based care,” said Kelly Bliss, President, U.S. Group Health at Teladoc Health. “We provide the integrated support necessary for patient safety and sustainable health outcomes. By integrating with LillyDirect, we are reducing barriers to high-quality care and helping our members afford transformative FDA-approved treatments while avoiding the potential risks of compounded medications recently offered by others.”